Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Investing Activities: 2021-2025

Historic Cash from Investing Activities for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to $1,000.

  • Biofrontera's Cash from Investing Activities was N/A to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4,000, marking a year-over-year change of. This contributed to the annual value of -$3,000 for FY2024, which is 100.48% down from last year.
  • Latest data reveals that Biofrontera reported Cash from Investing Activities of $1,000 as of Q3 2025, which was up 200.00% from -$1,000 recorded in Q2 2025.
  • Biofrontera's 5-year Cash from Investing Activities high stood at $382,000 for Q3 2023, and its period low was -$3.0 million during Q3 2022.
  • For the 3-year period, Biofrontera's Cash from Investing Activities averaged around $76,875, with its median value being $0 (2024).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 303,500.00% in 2022, then surged by 674.19% in 2023.
  • Quarterly analysis of 5 years shows Biofrontera's Cash from Investing Activities stood at -$9,000 in 2021, then slumped by 23,077.78% to -$2.1 million in 2022, then spiked by 103.50% to $73,000 in 2023, then slumped by 101.37% to -$1,000 in 2024, then reached $1,000 in 2025.
  • Its Cash from Investing Activities stands at $1,000 for Q3 2025, versus -$1,000 for Q2 2025 and -$3,000 for Q1 2025.